Anzeige
Mehr »
Login
Freitag, 19.04.2024 Börsentäglich über 12.000 News von 689 internationalen Medien
Goldaktie: Eine Erfolgsgeschichte, die seinesgleichen sucht, startet gerade richtig durch!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
GlobeNewswire (Europe)
140 Leser
Artikel bewerten:
(0)

Virbac: Sébastien Huron will become the new chairman of the executive board as of December 2017

Virbac group: Sébastien Huron will become the new chairman of the executive board as of December 2017

Carros, France - June 23, 2017

Virbac has announced the supervisory board's intention to appoint Sébastien Huron as chairman of Virbac's executive board, as of next December, when the mandate of the current chairman of the executive board, Éric Marée, expires.

At its annual shareholders' meeting held today, June 23, Virbac announces that Éric Marée, chairman of the executive board for the past 17 years, has informed the supervisory board of his wish not to serve another term once the current term ends on December 20, 2017 and is therefore retiring. Marie-Hélene Dick, chairwoman of the supervisory board, revealed the intention of the board, which met on June 22, to appoint Sébastien Huron chairman of the executive board once the current tenure of the executive board ends. Until then, Éric Marée, Sébastien Huron and the other members of the executive board will work closely together to prepare for this transition.

Marie-Hélene Dick, chairwoman of the Virbac supervisory board, has elaborated:
"Through his training as a veterinarian, his excellent knowledge of what's at stake in the global animal health market, his energy, his leadership qualities, and his perfect operational knowledge of Virbac during the past eleven years, including four on the executive board, the supervisory board has considered that the best choice to take up the future challenges and pursue the development of our Group in the long term while improving its profitability is to appoint Sébastien Huron to the post of chairman of the executive board, effective December 20, 2017."

Sébastien Huron, 46, DVM, started his career in 1994 in Brazil in the Hoechst-Roussel group where he rapidly rose to become the Marketing director of the animal health division. After Intervet acquired this division (Akzo Nobel group), which was then integrated into the Merck Group, Sébastien Huron pursued his career in 2000 in the United States as Market Development director, and then as director of the Pet division. After rejoining the Virbac group in 2006 as the general manager of the Spanish subsidiary, he then became the director of the European region in 2008, and then head of Global Business Operations in 2013. He has been part of the Virbac executive board since December 2012.

A LABORATORY THAT HAS ALWAYS BEEN DEDICATED TO ANIMAL HEALTH
Virbac offers veterinarians, farmers and pet owners in more than 100 countries a comprehensive and practical range of products and services. With these innovative solutions covering the majority of animal species and diseases, Virbac contributes, day after day, to shape the future of animal health.

Virbac:Sébastien Huron will become the new chairman of the executive b (http://hugin.info/136717/R/2115175/804795.pdf)



This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Virbac via Globenewswire

Großer Insider-Report 2024 von Dr. Dennis Riedl
Wenn Insider handeln, sollten Sie aufmerksam werden. In diesem kostenlosen Report erfahren Sie, welche Aktien Sie im Moment im Blick behalten und von welchen Sie lieber die Finger lassen sollten.
Hier klicken
© 2017 GlobeNewswire (Europe)
Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.